The results of the TUNEL assay and Ki67 immunofluorescence staining in mouse pancreatic tumor tissues indicated that the combined regimen notably increased the proportion of apoptotic cancer cells and reduced the proportion of proliferative cancer cells when compared with those in the monotherapy groups (Fig. 2M-N). This evidence concerns the gene MKI67 and cancer.